Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0007 (-6.14%)
At close: Dec 5, 2025

Petros Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
04356943
Upgrade
Market Cap Growth
-81.47%27.11%-35.68%-92.98%60.87%-
Upgrade
Enterprise Value
-67-646387
Upgrade
Last Close Price
0.019.8535.2558.25832.501100.00
Upgrade
PS Ratio
0.090.770.530.818.804.47
Upgrade
PB Ratio
0.14-0.530.250.291.932.44
Upgrade
P/TBV Ratio
0.14-1.001.086.70-
Upgrade
EV/Sales Ratio
-1.45-0.638.059.11
Upgrade
Debt / Equity Ratio
--0.990.660.590.020.45
Upgrade
Asset Turnover
0.380.230.180.120.110.15
Upgrade
Inventory Turnover
-0.420.711.962.502.73
Upgrade
Quick Ratio
2.190.231.451.630.870.53
Upgrade
Current Ratio
2.220.411.892.080.990.62
Upgrade
Return on Equity (ROE)
-565.29%-571.33%-55.95%-76.70%-33.90%-161.53%
Upgrade
Return on Assets (ROA)
-48.91%-28.97%-20.32%-19.84%-16.44%-16.85%
Upgrade
Return on Capital (ROIC)
-94.90%-62.25%-28.42%-31.61%-36.77%-45.21%
Upgrade
Return on Capital Employed (ROCE)
-311.60%139.30%-46.70%-62.50%-49.60%-61.80%
Upgrade
Earnings Yield
-12076.48%-362.97%-263.03%-415.29%-13.08%-48.20%
Upgrade
FCF Yield
-1038.67%-66.61%-245.74%-265.23%-17.26%-35.84%
Upgrade
Buyback Yield / Dilution
-7102.89%-268.84%-5.11%-90.11%-103.90%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.